Subscribe to Search results

Only 8Y was issued after this date.

Published on:

BPL and PFL heat-treated F9 became routinely available.

Published on:

Armour withdrew heat-treated Factorate following seroconversions.

Published on:

PFC issued Z8, the equivalent of 8Y free from hepatitis as well as HIV.

Published on:

First formal meeting of haemophilia centre directors took place.

Published on:

Dr Craske reported to the UK Haemophilia Centre Directors ("UKHCDO") hepatitis outbreak in Bournemouth linked to commercial Factor 8.

Published on:

Glasgow symposium considered liver disease in haemophilia.

Published on:

US Centers for Disease Control reported three confirmed cases of people with haemophilia who had developed AIDS.

Published on:

UKHCDO meeting referred to "remote possibility" that commercial blood products were the cause of AIDS in people with haemophilia in the US.

Published on:

Dr Craske's paper on AIDS made it clear that an infectious agent was the most likely cause.

Published on:

Letter from Professor Bloom and Dr Rizza regarding administration of factor concentrates to previously untreated patients.

Published on:

The New England Journal of Medicine warned of risks of AIDS to people with haemophilia and advocated a revised approach to treatment.

Published on:

AIDS discussed at Heathrow hotel meeting of haemophilia centre directors.

Published on:

Professor Bloom reported to CDSC a "probable" case of AIDS in one of his patients.

Published on:

Special meeting of reference centre directors discussed AIDS.

Published on:

Letter from Professor Bloom and Dr Rizza set out general recommendations for treatment agreed at the 13 May 1983 special meeting.

Published on:

Professor Bloom told UKHCDO meeting that there was "no proof that commercial concentrates were the cause of AIDS"; meeting agreed that patients "should not be encouraged to go over to cryoprecipitate for home therapy".

Published on:

UKHCDO released AIDS Advisory Document.

Published on:

Five commercial Factor 8 products (Hemofil, Kryobulin, Profilate, Factorate and Koate) were granted licences in the UK.

Published on:

World in Action: Blood Money was broadcast on television in the UK.

Published on: